277 related articles for article (PubMed ID: 12576872)
1. Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells.
Abraham S; Zhang W; Greenberg N; Zhang M
J Urol; 2003 Mar; 169(3):1157-61. PubMed ID: 12576872
[TBL] [Abstract][Full Text] [Related]
2. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix.
Ngamkitidechakul C; Burke JM; O'Brien WJ; Twining SS
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3135-41. PubMed ID: 11726614
[TBL] [Abstract][Full Text] [Related]
3. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.
Shi HY; Zhang W; Liang R; Abraham S; Kittrell FS; Medina D; Zhang M
Cancer Res; 2001 Sep; 61(18):6945-51. PubMed ID: 11559574
[TBL] [Abstract][Full Text] [Related]
4. Maspin reduces prostate cancer metastasis to bone.
Hall DC; Johnson-Pais TL; Grubbs B; Bernal R; Leach RJ; Padalecki SS
Urol Oncol; 2008; 26(6):652-8. PubMed ID: 18367129
[TBL] [Abstract][Full Text] [Related]
5. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
Zou Z; Zhang W; Young D; Gleave MG; Rennie P; Connell T; Connelly R; Moul J; Srivastava S; Sesterhenn I
Clin Cancer Res; 2002 May; 8(5):1172-7. PubMed ID: 12006534
[TBL] [Abstract][Full Text] [Related]
6. Maspin plays an essential role in early embryonic development.
Gao F; Shi HY; Daughty C; Cella N; Zhang M
Development; 2004 Apr; 131(7):1479-89. PubMed ID: 14985257
[TBL] [Abstract][Full Text] [Related]
7. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
8. Editorial: maspin as a molecular target for cancer therapy.
Domann FE; Futscher BW
J Urol; 2003 Mar; 169(3):1162-4. PubMed ID: 12576873
[No Abstract] [Full Text] [Related]
9. Maspin plays an important role in mammary gland development.
Zhang M; Magit D; Botteri F; Shi HY; He K; Li M; Furth P; Sager R
Dev Biol; 1999 Nov; 215(2):278-87. PubMed ID: 10545237
[TBL] [Abstract][Full Text] [Related]
10. Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells.
Cai Z; Zhou Y; Lei T; Chiu JF; He QY
Cancer; 2009 Jan; 115(1):36-48. PubMed ID: 19090015
[TBL] [Abstract][Full Text] [Related]
11. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
Chen Z; Fan Z; McNeal JE; Nolley R; Caldwell MC; Mahadevappa M; Zhang Z; Warrington JA; Stamey TA
J Urol; 2003 Apr; 169(4):1316-9. PubMed ID: 12629351
[TBL] [Abstract][Full Text] [Related]
12. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
[TBL] [Abstract][Full Text] [Related]
13. Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis.
Tahmatzopoulos A; Sheng S; Kyprianou N
Oncogene; 2005 Aug; 24(34):5375-83. PubMed ID: 16007219
[TBL] [Abstract][Full Text] [Related]
14. Maspin is an angiogenesis inhibitor.
Zhang M; Volpert O; Shi YH; Bouck N
Nat Med; 2000 Feb; 6(2):196-9. PubMed ID: 10655109
[TBL] [Abstract][Full Text] [Related]
15. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.
Cher ML; Biliran HR; Bhagat S; Meng Y; Che M; Lockett J; Abrams J; Fridman R; Zachareas M; Sheng S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7847-52. PubMed ID: 12788977
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressive maspin and epithelial homeostasis.
Lockett J; Yin S; Li X; Meng Y; Sheng S
J Cell Biochem; 2006 Mar; 97(4):651-60. PubMed ID: 16329135
[TBL] [Abstract][Full Text] [Related]
17. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
Zhang M; Maass N; Magit D; Sager R
Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
19. Maspin is up-regulated in premalignant prostate epithelia.
Pierson CR; McGowen R; Grignon D; Sakr W; Dey J; Sheng S
Prostate; 2002 Dec; 53(4):255-62. PubMed ID: 12430137
[TBL] [Abstract][Full Text] [Related]
20. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
